Espire Hospi

how big is Espire Hospi?

As of Jun 06, Espire Hospitality Ltd has a market capitalization of 694.00 Cr, with recent net sales of 118.75 Cr and a net profit of 8.27 Cr. Shareholder's funds are valued at 3.31 Cr, and total assets amount to 69.51 Cr.

Market Cap: As of Jun 06, Espire Hospitality Ltd has a market capitalization of 694.00 Cr, which categorizes it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the company reported Net Sales of 118.75 Cr and a Net Profit of 8.27 Cr. This data is based on Standalone financials.<BR><BR>Balance Sheet Snapshot: This is also based on Standalone data for the latest annual period ending in Mar'24. The Shareholder's Funds are valued at 3.31 Cr, while the Total Assets amount to 69.51 Cr.

What does Espire Hospi do?

Espire Hospitality Ltd operates in the Hotels & Resorts industry, reporting net sales of 41 Cr and a net profit of 4 Cr for the quarter ending March 2025. The company, with a market cap of Rs 701 Cr, has a P/E ratio of 84.00 and a return on equity of 191.44%.

Overview:<BR>Espire Hospitality Ltd operates in the Hotels & Resorts industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>Incorporated in October 1991, Espire Hospitality Ltd was formerly known as Wellesley Corporation Limited. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 41 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 4 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 701 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 84.00 <BR>Industry P/E: 33 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 17.16 <BR>Return on Equity: 191.44% <BR>Price to Book: 160.97<BR><BR>Contact Details:<BR>Address: Shop No 1 Country Inn, Mehragaon Bhimtal UTT : 248179 <BR>Tel: 91-011-2618 4535/2618 4411 <BR>Email: investor@wellesleycorp.com <BR>Website: http://www.espirehospitality.com

Has Espire Hospi declared dividend?

No Dividend History Available

Who are the peers of the Espire Hospi?

Espire Hospi's peers include Indian Hotels Co, ITC Hotels, EIH, Chalet Hotels, Ventive Hospital, Advani Hotels, The Byke Hospi, Sinclairs Hotels, Sayaji Hotels, and Phoenix Township. Espire Hospi has a below-average management risk and a 1-year return of 300.58%, the highest among its peers.

Peers: The peers of Espire Hospi are Indian Hotels Co, ITC Hotels, EIH, Chalet Hotels, Ventive Hospital, Advani Hotels, The Byke Hospi, Sinclairs Hotels, Sayaji Hotels, and Phoenix Township.<BR><BR>Quality Snapshot: Excellent management risk is observed at EIH and Sinclairs Hotels, while Average management risk is found at Indian Hotels Co and Advani Hotels. Below Average management risk is noted for Espire Hospi, Chalet Hotels, Ventive Hospital, The Byke Hospi, Sayaji Hotels, and Phoenix Township. Growth is rated as Excellent for Ventive Hospital, Good for Indian Hotels Co and EIH, Average for Espire Hospi, and Below Average for ITC Hotels, Chalet Hotels, Advani Hotels, The Byke Hospi, Sinclairs Hotels, and Sayaji Hotels. Capital Structure is Excellent for EIH and Advani Hotels, Good for The Byke Hospi, and Below Average for Espire Hospi, ITC Hotels, Chalet Hotels, Ventive Hospital, Sinclairs Hotels, and Sayaji Hotels.<BR><BR>Return Snapshot: Espire Hospi has a 1-year return of 300.58%, which is the highest among its peers, while Advani Hotels has the lowest at -11.04%. Espire Hospi's return significantly exceeds that of Advani Hotels. Additionally, the peers with negative six-month returns include EIH, Advani Hotels, Sinclairs Hotels, and Sayaji Hotels.

Who are in the management team of Espire Hospi?

As of March 2022, the management team of Espire Hospi includes Leela Rani Bisht (Director), Prithvi Raj Singh (Managing Director), Amit Rai (Director), Gagan Oberoi (Chairperson), Sumeer Narain Mathur (CFO & Company Secretary), and three Independent Directors: Pramod Bhatnagar, Dileep Kumar, and Amit Kumar Jain. They oversee the company's operations and strategic direction.

As of March 2022, the management team of Espire Hospi includes the following individuals:<BR><BR>1. Leela Rani Bisht - Director<BR>2. Prithvi Raj Singh - Managing Director<BR>3. Amit Rai - Director<BR>4. Gagan Oberoi - Chairperson<BR>5. Sumeer Narain Mathur - CFO & Company Secretary<BR>6. Pramod Bhatnagar - Independent Director<BR>7. Dileep Kumar - Independent Director<BR>8. Amit Kumar Jain - Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Who are the top shareholders of the Espire Hospi?

The top shareholders of Espire Hospi are primarily the promoters, with Mrs. Sadhana Rai holding 67.01%. Other significant shareholders include Rajesh Kumar Gupta at 6.96%, individual investors with 18.5%, and a foreign institutional investor with 2.08%.

The top shareholders of Espire Hospi include the promoters, with Mrs. Sadhana Rai holding the largest share at 67.01%. There are no pledged promoter holdings. Additionally, Rajesh Kumar Gupta is the highest public shareholder, owning 6.96%. The company also has individual investors holding a combined 18.5%, and there is one foreign institutional investor (FII) that holds 2.08%. Overall, the majority of the shares are held by the promoters.

How has been the historical performance of Espire Hospi?

Espire Hospi has shown significant growth from March 2022 to March 2025, with net sales increasing from 1.69 Cr to 119.55 Cr, and profitability improving with profit after tax rising to 8.27 Cr from a loss. The company's total assets and equity reserves also expanded notably during this period.

Answer:<BR>The historical performance of Espire Hospi shows significant growth in net sales and profitability over the years, particularly from March 2023 to March 2025.<BR><BR>Breakdown:<BR>Espire Hospi's net sales have increased dramatically from 1.69 Cr in March 2022 to 119.55 Cr in March 2025, indicating a strong upward trend. Total operating income followed a similar trajectory, reaching 119.55 Cr in March 2025, up from just 1.69 Cr in March 2022. The company has also improved its operating profit, which turned positive in March 2022 and rose to 23.08 Cr by March 2025. Profit before tax also saw a notable increase, moving from a mere 0.03 Cr in March 2022 to 10.81 Cr in March 2025, while profit after tax reached 8.27 Cr in March 2025, compared to a loss of 0.08 Cr in March 2022. The company's total assets grew significantly from 7.29 Cr in March 2022 to 181.20 Cr in March 2025, reflecting a robust expansion. Total liabilities also increased, from 7.29 Cr in March 2022 to 181.20 Cr in March 2025, primarily driven by long-term borrowings which rose to 69.93 Cr. Despite the increase in liabilities, the company's equity capital and reserves improved, with reserves turning positive at 28.58 Cr in March 2025, up from negative values in previous years. Overall, Espire Hospi's financial performance indicates a strong growth trajectory with improving profitability and asset base.

Is Espire Hospi technically bullish or bearish?

As of November 17, 2025, the market trend is bearish with moderate strength, supported by bearish indicators from the MACD, moving averages, and Bollinger Bands, despite some bullish momentum in the RSI.

As of 17 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. The weekly MACD is bearish, and the daily moving averages confirm a bearish outlook. The weekly Bollinger Bands also indicate a bearish trend, while the KST is bearish on the weekly timeframe. Although the weekly RSI shows bullish momentum, it is not sufficient to counter the overall bearish indicators. The Dow Theory indicates no trend on the weekly level and mildly bearish on the monthly level, further supporting the bearish stance.

Is Espire Hospi overvalued or undervalued?

As of November 20, 2025, Espire Hospi is considered overvalued with a PE ratio of 169.37, significantly higher than its peers, and despite impressive long-term returns, it has recently underperformed compared to the Sensex.

As of 20 November 2025, the valuation grade for Espire Hospi has moved from very expensive to expensive, indicating a slight improvement but still suggesting high valuation concerns. The company is currently considered overvalued based on its elevated financial ratios, including a PE ratio of 169.37, an EV to EBITDA of 28.88, and a PEG ratio of 70.04, which are significantly higher than industry norms.<BR><BR>In comparison to its peers, Espire Hospi's PE ratio far exceeds that of JSW Steel at 46.74 and Tata Steel at 28.92, both of which are rated as fair and attractive, respectively. This stark contrast highlights the overvaluation of Espire Hospi in the current market. Additionally, while the company has shown impressive returns over the past few years, including a staggering 2495.27% over three years, its recent performance has lagged behind the Sensex, with a 1-month return of -22.85% compared to the Sensex's 1.50%.

When is the next results date for Espire Hospitality Ltd?

The next results date for Espire Hospitality Ltd is 13 February 2026.

The next results date for Espire Hospitality Ltd is scheduled for 13 February 2026.

Are Espire Hospitality Ltd latest results good or bad?

Espire Hospitality Ltd's latest Q2 FY26 results are poor, showing a net profit of ₹-5.71 crores and a 40.40% drop in revenue to ₹18.90 crores, alongside a negative operating margin of -10.74%. These figures indicate significant operational challenges and financial strain, raising concerns about the company's future performance.

Espire Hospitality Ltd's latest results for Q2 FY26 indicate a significant decline in performance, which can be characterized as poor. The company reported a net profit of ₹-5.71 crores, reflecting a staggering drop of 499.30% quarter-on-quarter. Revenue also fell sharply by 40.40% to ₹18.90 crores, marking the lowest quarterly revenue in the past twelve months.<BR><BR>The operating margin turned negative at -10.74%, a drastic decline from the previous quarter's 23.94%. This operational collapse suggests serious challenges within the company, as it struggles to maintain profitability amidst rising costs and declining revenues. The return on equity, while historically strong at an average of 24.87%, has recently dropped to 6.90%, further highlighting the current difficulties.<BR><BR>Overall, the results indicate that Espire Hospitality is facing significant operational challenges and financial strain, raising concerns about its future performance and sustainability in the competitive hospitality sector. Investors may need to reassess their positions in light of these developments.

Should I buy, sell or hold Espire Hospitality Ltd?

Why is Espire Hospitality Ltd falling/rising?

As of 25-May, Espire Hospitality Ltd's stock price has risen by 3.22% after two days of decline, indicating a potential trend reversal. However, it has a year-to-date drop of 28.42% and declining investor interest, suggesting caution despite the short-term recovery.

As of 25-May, Espire Hospitality Ltd's stock price is rising, having increased by 6.65 points, or 3.22%. This upward movement follows two consecutive days of decline, indicating a potential trend reversal. The stock opened with a significant gain of 8.61% today and reached an intraday high of Rs 224. Additionally, it has outperformed its sector by 2.75%. <BR><BR>Despite the positive performance today, the stock has experienced a notable decline over the longer term, with a year-to-date drop of 28.42% and a one-year decrease of 49.31%. However, the recent increase in price suggests a short-term recovery, even as investor participation has been falling, with delivery volume on 22 May down by 67.83% compared to the five-day average. <BR><BR>Overall, while the stock is currently rising, it is essential to consider the broader context of its recent performance and declining investor interest.

Which are the latest news on Espire Hospi?